This Future of HIV Prevention?? — Meet The Revolutionary 2 Monthly Injection (Apretude)

Discover how Cabotegravir PrEP injections are transforming HIV prevention worldwide. In this video, we break down how a single injection can protect you from HIV for up to two months, why long-acting PrEP is more effective for many people than daily pills, and the powerful science behind long-acting integrase inhibitors. Whether you’re new to PrEP, currently taking daily tablets, or just curious about the future of HIV prevention, this video explains everything in simple, clear language. On World AIDS Day, it’s more important than ever to highlight innovations that help reduce new HIV infections and widen global access to prevention. We also explore real-world advantages of Cabotegravir — from fewer daily reminders to better privacy, improved consistency, and increased access for people who travel, face stigma, or struggle with adherence. You’ll learn how countries around the world are rolling out long-acting PrEP, why global health experts consider it one of the biggest breakthroughs since oral PrEP, and how this one injection every two months could dramatically reduce new HIV cases over the next decade. If you’re passionate about sexual health, prevention science, or evidence-based medicine, this video is for you. For more detailed guidance and scientific data on long-acting injectable PrEP and Cabotegravir, see: CDC guidance on injectable PrEP / Cabotegravir – “Clinical Recommendation for the Use of Injectable Cabotegravir-PrEP” WHO guideline on CAB-LA for HIV prevention NIH / HIVinfo fact sheet on long-acting HIV medicines FDA approval announcement for Apretude (Cabotegravir LA) Link to the paper: https://www.nejm.org/doi/full/10.1056... Connect With Me- Instagram-   / abhishekkatiyaryt   TikTok- https://www.tiktok.com/@abhishekkatiy... Patreon-   / membership   Buy Me A Coffee- http://buymeacoffee.com/AbhishekYT